Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique

Journal of Infectious Diseases

Volumn 210, Issue 4, 2014, Pages 641-645

  Micek, Mark A ^a,b   Dross, Sandra ^a,c   Blanco, Ana Judith ^a,b   Beck, Ingrid A ^c   Matunha, Laurinda ^b   Seidel, Kristy ^c   Montoya, Pablo ^a,b   Matediana, Eduardo ^d   Gantt, Soren ^a,c   Gloyd, Stephen ^a,b   Frenkel, Lisa ^a,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b HEALTH ALLIANCE INTERNATIONAL   (United States)

^c SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^d Mozambique Ministry of Health   (United States)

Author keywords

Drug resistance; HIV 1; Mother to child transmission; Nevirapine; Zidovudine

Indexed keywords

NEVIRAPINE;

ANTIVIRAL RESISTANCE; ARTICLE; BREAST MILK; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION PREVENTION; INFECTION RISK; MOZAMBIQUE; NEWBORN; NUCLEOTIDE SEQUENCE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIRUS CONCENTRATION; VIRUS DETECTION; VIRUS RESISTANCE; VIRUS TRANSMISSION;

DRUG-RESISTANCE; HIV-1; MOTHER-TO-CHILD TRANSMISSION; NEVIRAPINE; ZIDOVUDINE;

ANTI-HIV AGENTS; BREAST FEEDING; DRUG RESISTANCE, VIRAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MILK, HUMAN; MOZAMBIQUE; NEVIRAPINE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES;

EID: 84905583613     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiu130     Document Type: Article

References (13)

1. UNAIDS. Global Report, UNAIDS Report on the Global AIDS Epidemic: 2012. Geneva: Joint United Nations Programme on HIV/ AIDS, 2012.
2. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection; recommendations for a public health approach. Geneva: World Health Organization, 2013.
3. Micek MA, Blanco AJ, Beck IA, et al. Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine. Clin Infect Dis 2010; 50: 1405-14.
4. Coovadia A, Abrams EJ, Stehlau R, et al. Reuse of nevirapine in exposed HIV-infected children after protease inhibitor-based viral suppression: a randomized controlled trial. JAMA 2010; 304: 1082-90.
5. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002; 347: 385-94.
6. Chan KC, Galli RA, Montaner JS, Harrigan PR. Prolonged retention of drug resistance mutations and rapid disease progression in the absence of therapy after primary HIV infection. Aids 2003; 17: 1256-8.
7. Eshleman SH, Mracna M, Guay LA, et al. Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). Aids 2001; 15: 1951-7.
8. Church JD, Omer SB, Guay LA, et al. Analysis of nevirapine (NVP) resistance in Ugandan infants who were HIV infected despite receiving single-Dose (SD) NVP versus SD NVP plus daily NVP up to 6 weeks of age to prevent HIV vertical transmission. J Infect Dis 2008; 198: 1075-82.
9. Moorthy A, Gupta A, Bhosale R, et al. Nevirapine resistance and breastmilk HIV transmission: effects of single and extended-dose nevirapine prophylaxis in subtype C HIV-infected infants. PLoS One 2009; 4: e4096.
10. Lee EJ, Kantor R, Zijenah L, et al. Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine. J Infect Dis 2005; 192: 1260-4.
11. Gantt S, Payant R, Carlsson J, et al. Nevirapine-Resistant HIV-1 DNA in Breast Milk After Single-Dose NevirapineWith orWithout Zidovudine for Prevention of Mother-to-Child Transmission. J Pediatric Infect Dis Soc 2012; 1: 244-9.
12. Zeh C, Weidle PJ, Nafisa L, et al. HIV-1 drug resistance emergence among breastfeeding infants born to HIV-infected mothers during a single-arm trial of triple-antiretroviral prophylaxis for prevention of mother-to-child transmission: a secondary analysis. PLoS Med 2011; 8: e1000430.
13. Gupta RK, Jordan MR, Sultan BJ, et al. Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. Lancet 2012;380: 1250-8.